Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids

British Journal of Haematology

Volumn 157, Issue 2, 2012, Pages 249-252

  Vasavda, Nisha ^a   Woodley, Claire ^b   Allman, Marlene ^c   Drašar, Emma ^c   Awogbade, Moji ^c   Howard, Jo ^b   Thein, Swee L ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alpha thalassaemia; Cell free DNA; Hydroxycarbamide; Sickle cell disease

Indexed keywords

CELL FREE DNA; DNA; HYDROXYUREA; NUCLEIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALPHA THALASSEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; COMORBIDITY; DNA DETERMINATION; DNA EXTRACTION; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT DURATION; TREATMENT RESPONSE; UNITED KINGDOM;

ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; FEMALE; HUMANS; HYDROXYUREA; INFANT; MALE; NUCLEIC ACIDS;

EID: 84859217638     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08937.x     Document Type: Letter

References (10)

1. Ballas, S.K. (2001) Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Pediatric Pathology & Molecular Medicine, 20, 107-121.
2. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New England Journal of Medicine, 332, 1317-1322.
3. Ferster, A., Tahriri, P., Vermylen, C., Sturbois, G., Corazza, F., Fondu, P., Devalck, C., Dresse, M.F., Feremans, W., Hunninck, K., Toppet, M., Philippet, P., Van Geet, C. & Sariban, E. (2001) Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood, 97, 3628-3632.
4. Steinberg, M.H. & Embury, S.H. (1986) Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood, 68, 985-990.
5. Steinberg, M.H., Lu, Z.H., Barton, F.B., Terrin, M.L., Charache, S. & Dover, G.J. (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood, 89, 1078-1088.
6. Ulug, P., Vasavda, N., Kumar, R., Keir, L., Awogbade, M., Cunningham, J., Rees, D.C., Menzel, S. & Thein, S.L. (2008) Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia. American Journal of Hematology, 83, 714-716.
7. Vasavda, N., Ulug, P., Kondaveeti, S., Ramasamy, K., Sugai, T., Cheung, G., Rees, D.C., Awogbade, M., Bannister, S., Cunningham, J., Menzel, S. & Thein, S.L. (2007) Circulating DNA: a potential marker of sickle cell crisis. British Journal of Haematology, 139, 331-336.
8. Vasavda, N., Badiger, S., Rees, D., Height, S., Howard, J. & Thein, S.L. (2008) The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease. British Journal of Haematology, 143, 589-592.
9. Voskaridou, E., Christoulas, D., Bilalis, A., Plata, E., Varvagiannis, K., Stamatopoulos, G., Sinopoulou, K., Balassopoulou, A., Loukopoulos, D. & Terpos, E. (2010) The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood, 115, 2354-2363.
10. Ware, R.E. & Aygun, B. (2009) Advances in the use of hydroxyurea. Hematology American Society of Hematology Education Program, 2009, 62-69.